Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MFC
MFC logo

MFC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Manulife Financial Corp (MFC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
41.400
1 Day change
0.10%
52 Week Range
41.700
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

MFC is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a constructive technical setup and mildly bullish options sentiment, but there is no fresh catalyst, analyst targets are only slightly mixed, and the latest available signals do not show a compelling edge. Since the user is impatient and does not want to wait for a better entry, my direct view is to hold off on buying today and wait for a clearer pullback or a stronger catalyst.

Technical Analysis

The trend is bullish in the short to medium term. MACD histogram is positive and expanding, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. RSI_6 at 72.384 suggests the stock is somewhat extended near term, even though it is labeled neutral in the source data. Price closed at 41.18, just above pivot 40.373 and near resistance R1 41.03 and R2 41.436, which means upside from here is possible but not obviously attractive for a fresh long entry. The recent pattern-based outlook is mixed-to-slightly positive over the next week, but weaker over the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish. The put-call ratios for both open interest and volume are low, showing more call activity than put activity. Open interest put-call ratio of 0.33 and volume put-call ratio of 0.09 indicate traders are leaning bullish. Implied volatility at 22.07 is moderate, IV rank at 6.1 is low, and IV percentile at 39.68 is also not elevated, so the options market is not pricing in major event risk. Overall, options positioning supports a positive bias, but it is not a strong enough signal by itself to justify an urgent buy.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • ["Bullish moving average alignment suggests an ongoing uptrend.", "MACD is positive and expanding, showing improving momentum.", "Options positioning is bullish with low put-call ratios.", "Analyst ratings remain generally constructive, with multiple Buy/Outperform ratings.", "No recent negative news flow, which helps keep sentiment stable."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh catalyst to drive a quick re-rating.", "RSI is elevated enough to suggest the stock is near-term extended.", "Analyst target changes were mixed and only modestly adjusted.", "Hedge funds and insiders are both neutral, indicating no strong conviction buying.", "Pattern-based forecast turns weaker over the next month.", "No recent congress trading data or influential figure activity to support a catalyst view."]

Financial Performance

No usable latest-quarter financial snapshot was provided because the financial data extraction failed. As a result, there is no reliable quarter-by-quarter revenue, earnings, or growth read here. For this report, the latest quarter season cannot be confirmed from the supplied data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst activity is mildly positive but not strongly bullish. Scotiabank lowered its target slightly to C$56 from C$57 while keeping Outperform; Evercore ISI raised its target to C$54 from C$53 and kept In Line; TD Securities lowered its target to C$58 from C$59 and kept Buy; Scotiabank also earlier raised its target to C$57 from C$56 and kept Outperform. Overall, the Wall Street pros view is favorable, with Buy/Outperform ratings dominating, but the target changes are small and mixed, suggesting limited near-term enthusiasm rather than strong conviction.

Wall Street analysts forecast MFC stock price to fall
11 Analyst Rating
Wall Street analysts forecast MFC stock price to fall
9 Buy
2 Hold
0 Sell
Strong Buy
Current: 41.360
sliders
Low
37.21
Averages
40.09
High
51
Current: 41.360
sliders
Low
37.21
Averages
40.09
High
51
Barclays
Equal Weight
maintain
$52 -> $56
AI Analysis
2026-07-07
New
Reason
Barclays
Price Target
$52 -> $56
AI Analysis
2026-07-07
New
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Manulife Financial to C$56 from C$52 and keeps an Equal Weight rating on the shares.
Scotiabank
Outperform
to
NULL
downgrade
$57 -> $56
2026-05-15
Reason
Scotiabank
Price Target
$57 -> $56
2026-05-15
downgrade
Outperform
to
NULL
Reason
Scotiabank lowered the firm's price target on Manulife Financial to C$56 from C$57 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MFC
Unlock Now

People Also Watch